ONWARD marks commercial breakthrough with FDA green light for ARC-EX
Post-market yesterday, ONWARD announced it has received De Novo FDA approval for ARC-EX Therapy to improve upper limb mobility in SCI patients, meeting both the timeline and positive clearance expectations. This milestone marks the first product launch from ONWARD’s enriched pipeline, aimed at addr
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.